Clinical Trial Update: Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety of Varivax in pediatric renal transplant recipients and was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplant Recipients | Phase 1 | Status: TERMINATED